175 related articles for article (PubMed ID: 37106459)
1. Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations.
Zhu X; Lv J; Zhu M; Yan C; Deng B; Yu C; Guo Y; Ni J; She Q; Wang T; Wang J; Jiang Y; Chen J; Hang D; Song C; Gao X; Wu J; Dai J; Ma H; Yang L; Chen Y; Song M; Wei Q; Chen Z; Hu Z; Shen H; Ding Y; Li L; Jin G
BMC Med; 2023 Apr; 21(1):159. PubMed ID: 37106459
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study.
Cai Q; Zhu C; Yuan Y; Feng Q; Feng Y; Hao Y; Li J; Zhang K; Ye G; Ye L; Lv N; Zhang S; Liu C; Li M; Liu Q; Li R; Pan J; Yang X; Zhu X; Li Y; Lao B; Ling A; Chen H; Li X; Xu P; Zhou J; Liu B; Du Z; Du Y; Li Z;
Gut; 2019 Sep; 68(9):1576-1587. PubMed ID: 30926654
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of a risk assessment tool for the personalized screening of breast cancer in Chinese populations: A prospective cohort study.
Zhu J; Wang L; Gong W; Li X; Wang Y; Zhu C; Li H; Shi L; Yang C; Du L
Cancer; 2024 Apr; 130(S8):1403-1414. PubMed ID: 37916832
[TBL] [Abstract][Full Text] [Related]
4. Stomach cancer screening and preventive behaviors in relatives of gastric cancer patients.
Kang JM; Shin DW; Kwon YM; Park SM; Park MS; Park JH; Son KY; Cho BL
World J Gastroenterol; 2011 Aug; 17(30):3518-25. PubMed ID: 21941419
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic findings in a mass screening program for gastric cancer in a high risk region - Guilan province of Iran.
Mansour-Ghanaei F; Sokhanvar H; Joukar F; Shafaghi A; Yousefi-Mashhour M; Valeshabad AK; Fakhrieh S; Aminian K; Ghorbani K; Taherzadeh Z; Sheykhian MR; Rajpout Y; Mehrvarz A
Asian Pac J Cancer Prev; 2012; 13(4):1407-12. PubMed ID: 22799340
[TBL] [Abstract][Full Text] [Related]
6. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
[TBL] [Abstract][Full Text] [Related]
7. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations.
Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H
Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317
[TBL] [Abstract][Full Text] [Related]
8. Stomach Cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population.
Wu BU; Dong EY; Chen Q; Luong TQ; Lustigova E; Jeon CY; Chen W
PLoS One; 2024; 19(5):e0303153. PubMed ID: 38771811
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China.
Hu Y; Bao H; Jin H; Zhao J; Xu Y; Huang X; Liu S; Lu B
Gastric Cancer; 2021 Nov; 24(6):1194-1202. PubMed ID: 34152518
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.
Zhou R; Zheng H; Liu M; Liu Z; Guo C; Tian H; Liu F; Liu Y; Pan Y; Chen H; Hu Z; Cai H; He Z; Ke Y
Chin J Cancer Res; 2021 Dec; 33(6):649-658. PubMed ID: 35125809
[TBL] [Abstract][Full Text] [Related]
11. The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study.
Shen M; Xia R; Luo Z; Zeng H; Wei W; Zhuang G; Zhang L; Chen W
J Theor Biol; 2020 Jan; 484():109996. PubMed ID: 31491497
[TBL] [Abstract][Full Text] [Related]
12. Initial results from a multi-center population-based cluster randomized trial of esophageal and gastric cancer screening in China.
Zeng H; Sun K; Cao M; Zheng R; Sun X; Liu S; Zhang Z; Liu Y; Guo G; Song G; Zhu Y; Wu X; Song B; Liao X; Chen Y; Song M; Giovannucci E; Zhuang G; Wei W; Chen W; He J
BMC Gastroenterol; 2020 Nov; 20(1):398. PubMed ID: 33228549
[TBL] [Abstract][Full Text] [Related]
13. Genetic risk, incident gastric cancer, and healthy lifestyle: a meta-analysis of genome-wide association studies and prospective cohort study.
Jin G; Lv J; Yang M; Wang M; Zhu M; Wang T; Yan C; Yu C; Ding Y; Li G; Ren C; Ni J; Zhang R; Guo Y; Bian Z; Zheng Y; Zhang N; Jiang Y; Chen J; Wang Y; Xu D; Zheng H; Yang L; Chen Y; Walters R; Millwood IY; Dai J; Ma H; Chen K; Chen Z; Hu Z; Wei Q; Shen H; Li L
Lancet Oncol; 2020 Oct; 21(10):1378-1386. PubMed ID: 33002439
[TBL] [Abstract][Full Text] [Related]
14. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
Quach DT; Hiyama T; Gotoda T
World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a risk assessment tool for gastric cancer in a general Japanese population.
Iida M; Ikeda F; Hata J; Hirakawa Y; Ohara T; Mukai N; Yoshida D; Yonemoto K; Esaki M; Kitazono T; Kiyohara Y; Ninomiya T
Gastric Cancer; 2018 May; 21(3):383-390. PubMed ID: 29043529
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.
Kapoor R; So JBY; Zhu F; Too HP; Yeoh KG; Yoong JS
Value Health; 2020 Sep; 23(9):1171-1179. PubMed ID: 32940235
[TBL] [Abstract][Full Text] [Related]
17. [Polygenic risk score in personalized screening of lung cancer: a prospective cohort study in Chinese].
Zhu M; Lyu J; Yu CQ; Huang YQ; Ma HX; Jin GF; Guo Y; Pei P; Chen ZM; Shen HB; Hu ZB; Li LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Mar; 42(3):376-381. PubMed ID: 34814406
[No Abstract] [Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study.
Chen Q; Yu L; Hao CQ; Wang JW; Liu SZ; Zhang M; Zhang SK; Guo LW; Quan PL; Zhao N; Zhang YW; Sun XB
Cancer Med; 2016 Sep; 5(9):2615-22. PubMed ID: 27367362
[TBL] [Abstract][Full Text] [Related]
20. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
